HIMACS (4299) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
20 Jul, 2026Executive summary
Net sales for the three months ended June 30, 2024, were ¥4,327 million, nearly flat year-over-year (down 0.2%).
Operating profit rose 5.7% year-over-year to ¥301 million, while ordinary profit increased 5.6% to ¥303 million.
Profit attributable to owners of parent grew 5.7% year-over-year to ¥207 million.
Earnings per share increased to ¥17.90 from ¥16.84 in the prior year period.
Financial highlights
Gross profit improved to ¥915 million from ¥887 million year-over-year.
Selling, general and administrative expenses rose to ¥614 million from ¥602 million.
Total assets decreased to ¥13,299 million as of June 30, 2024, from ¥13,590 million at March 31, 2024.
Net assets declined slightly to ¥10,883 million from ¥10,935 million at the previous fiscal year-end.
Net cash used in operating activities was ¥84 million, compared to ¥15 million in the prior year period.
Outlook and guidance
Full-year net sales forecast is ¥18,600 million, up 7.2% year-over-year.
Full-year operating profit is projected at ¥1,780 million, up 3.4% year-over-year.
Full-year profit attributable to owners of parent is forecast at ¥1,220 million, up 3.1% year-over-year.
Full-year earnings per share forecast is ¥105.32.
Dividend forecast for the year ending March 31, 2025, is ¥44.00 per share.
Latest events from HIMACS
- Profits and sales rose year-over-year, with strong outlook and higher dividend forecast.4299
Q2 202520 Jul 2026 - Sales and profits rose, with FY2026 sales growth forecast but lower net profit expected.4299
Q4 202520 Jul 2026 - Profits and sales rose year-over-year, with a higher full-year outlook and dividend forecast.4299
Q3 202520 Jul 2026 - Sales rose, but profits fell sharply; full-year outlook sees higher revenue but lower net income.4299
Q1 202620 Jul 2026 - Sales rose modestly, but profits declined; full-year outlook expects higher sales and stable margins.4299
Q2 202620 Jul 2026 - Revenue grew slightly, but profits and cash reserves declined due to higher expenses and share buybacks.4299
Q3 202620 Jul 2026 - Sales rose modestly, but profits fell and next year's earnings are forecast to decline further.4299
Q4 202620 Jul 2026